{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:27:58Z","timestamp":1780990078747,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14069-1","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:35:43Z","timestamp":1770262543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advancing youth HIV prevention and care in Uganda: stakeholder-informed innovations through implementation science, protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Enid","family":"Kabugho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Gati","family":"Mirembe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Mwangwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodgers","family":"Katwesigye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Paul","family":"Kisitu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiphas","family":"Owaraganise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Namusoke-Magongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses R.","family":"Kamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dithan","family":"Kiragga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Nahirya","family":"Ntege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred Collins","family":"Semitala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Musoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"14069_CR1","unstructured":"UNAIDS. IN DANGER. UNAIDS Global AIDS Update 2022. Geneva: UNAIDS; 2022."},{"key":"14069_CR2","doi-asserted-by":"crossref","unstructured":"Patton GC, Sawyer SM, Santelli JS, Ross DA, Afifi R, Allen NB, et al. Our future: a Lancet commission on adolescent health and wellbeing. Lancet. 2016;387(10036):2423\u201378.","DOI":"10.1016\/S0140-6736(16)00579-1"},{"key":"14069_CR3","unstructured":"World Bank. Uganda Economic Update. Economic development and Human capital in Uganda - a case for investing more in education. 13th 2019. May. Washington, DC: World Bank; 2019."},{"key":"14069_CR4","doi-asserted-by":"crossref","unstructured":"Poulin C, Alary M, Bernier F, Carbonneau D, Boily MC, Joly JR. Prevalence of Chlamydia trachomatis and neisseria gonorrheae among at-risk women, young sex workers, and street youth attending community organizations in Quebec city, Canada. Sex Transm Dis. 2001;28(8):437\u201343.","DOI":"10.1097\/00007435-200108000-00002"},{"issue":"12","key":"14069_CR5","doi-asserted-by":"publisher","first-page":"e844","DOI":"10.1016\/S2352-3018(20)30269-1","volume":"7","author":"S Day","year":"2020","unstructured":"Day S, Kapogiannis BG, Shah SK, Wilson EC, Ruel TD, Conserve DF, et al. Adolescent participation in HIV research: consortium experience in low and middle-income countries and scoping review. Lancet HIV. 2020;7(12):e844\u201352.","journal-title":"Lancet HIV"},{"issue":"15","key":"14069_CR6","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1097\/QAD.0000000000003049","volume":"35","author":"JD Tucker","year":"2021","unstructured":"Tucker JD, Iwelunmor J, Abrams E, Donenberg G, Wilson EC, Blachman-Demner D, et al. Accelerating adolescent HIV research in low-income and middle-income countries: evidence from a research consortium. AIDS. 2021;35(15):2503\u201311.","journal-title":"AIDS"},{"key":"14069_CR7","volume-title":"Population-based HIV impact assessment (UPHIA 2020-2021): summary sheet","author":"Ministry of Health (MOH)","year":"2022","unstructured":"Ministry of Health (MOH). Population-based HIV impact assessment (UPHIA 2020-2021): summary sheet. Kampala: Uganda Ministry of Health; ICAP; 2022."},{"key":"14069_CR8","volume-title":"Addressing the structural drivers of HIV: a STRIVE synthesis","author":"STRIVE","year":"2019","unstructured":"STRIVE. Addressing the structural drivers of HIV: a STRIVE synthesis. London: London School of Hygiene & Tropical Medicine; 2019."},{"issue":"S2","key":"14069_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/09540121.2016.1176673","volume":"28","author":"J Busza","year":"2016","unstructured":"Busza J, Mtetwa S, Mapfumo R, Hanisch D, Wong-Gruenwald R, Cowan F. Underage and underserved: reaching young women who sell sex in Zimbabwe. AIDS Care. 2016;28(S2):14\u201320.","journal-title":"AIDS Care"},{"key":"14069_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/1471-2458-10-530","volume":"10","author":"G Nalwadda","year":"2010","unstructured":"Nalwadda G, Mirembe F, Byamugisha J, Faxelid E. Persistent high fertility in Uganda: young people recount obstacles and enabling factors to use of contraceptives. BMC Public Health. 2010;10:530.","journal-title":"BMC Public Health"},{"key":"14069_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/00020180220140091","volume":"61","author":"M Hunter","year":"2002","unstructured":"Hunter M. The materiality of everyday sex: thinking beyond \u201cprostitution\u2019\u2019. Afr Stud. 2002;61:99\u2013120.","journal-title":"Afr Stud"},{"key":"14069_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1186\/1471-2458-13-741","volume":"13","author":"M Mbonye","year":"2013","unstructured":"Mbonye M, Nakamanya S, Nalukenge W, King R, Vandepitte J, Seeley J. \u2018It is like a tomato stall where someone can pick what he likes\u2019: structure and practices of female sex work in Kampala, Uganda. BMC Public Health. 2013;13:741.","journal-title":"BMC Public Health"},{"issue":"7","key":"14069_CR13","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1007\/s10461-010-9693-0","volume":"15","author":"CL Miller","year":"2011","unstructured":"Miller CL, Bangsberg DR, Tuller DM, et al. Food insecurity and sexual risk in an HIV endemic community in Uganda. AIDS Behav. 2011;15(7):1512\u201319.","journal-title":"AIDS Behav"},{"key":"14069_CR14","unstructured":"Bantebya G, Muhanguzi F, Watson C. Adolescent girls in the balance: changes and continuity in social norms and practices around marriage and education in Uganda. Kampala; 2014."},{"key":"14069_CR15","volume-title":"Cross-generational and transactional sexual relations in sub-Saharan Africa: prevalence of behavior and implications for negotiating safer sexual practices","author":"N Luke","year":"2002","unstructured":"Luke N, Kurz K. Cross-generational and transactional sexual relations in sub-Saharan Africa: prevalence of behavior and implications for negotiating safer sexual practices. Washington, DC: International Center for Research on Women; 2002."},{"key":"14069_CR16","first-page":"89","volume":"7","author":"JK Konde-Lule","year":"1997","unstructured":"Konde-Lule JK, Sewankambo NK, Morris M. Adolescent sexual networking and HIV transmission in rural Uganda. Health Transit Rev. 1997;7:89\u2013100.","journal-title":"Health Transit Rev"},{"issue":"7","key":"14069_CR17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1473-3099(13)70363-3","volume":"14","author":"ED Lowenthal","year":"2014","unstructured":"Lowenthal ED, Bakeera-Kitaka S, Marukutira T, Chapman J, Goldrath K, Ferrand RA. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. Lancet Infect Dis. 2014;14(7):627\u201339.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"14069_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S1473-3099(12)70066-X","volume":"12","author":"S Baral","year":"2012","unstructured":"Baral S, Beyrer C, Muessig K, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(7):538\u201349.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"14069_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/QAI.0b013e3182a98ee6","volume":"65","author":"SM Goldenberg","year":"2014","unstructured":"Goldenberg SM, Chettiar J, Simo A, Silverman JG, Strathdee SA, Montaner JS, et al. Early sex work initiation independently elevates odds of HIV infection and police arrest among adult sex workers in a Canadian setting. J Acquir Immune Defic Syndr. 2014;65(1):122\u201328.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"14069_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s12889-017-4428-z","volume":"17","author":"W Hladik","year":"2017","unstructured":"Hladik W, Baughman AL, Serwadda D, Tappero JW, Kwezi R, Nakato ND, et al. Burden and characteristics of HIV infection among female sex workers in Kampala, Uganda - a respondent-driven sampling survey. BMC Public Health. 2017;17(1):565.","journal-title":"BMC Public Health"},{"issue":"4","key":"14069_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/imig.12104","volume":"52","author":"S Goldenberg","year":"2014","unstructured":"Goldenberg S, Silverman J, Engstrom D, Bojorquez-Chapela I, Strathdee S. \u201cRight here is the gateway\u201d: mobility, sex work entry and HIV risk along the mexico-U.S. border. Int Migr. 2014;52(4):26\u201340.","journal-title":"Int Migr"},{"issue":"5","key":"14069_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/adc.2009.178715","volume":"96","author":"JG Silverman","year":"2011","unstructured":"Silverman JG. Adolescent female sex workers: invisibility, violence and HIV. Arch Dis Child. 2011;96(5):478\u201381.","journal-title":"Arch Dis Child"},{"issue":"Suppl 1","key":"14069_CR23","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/QAD.0000000000003158","volume":"36","author":"J Saul","year":"2022","unstructured":"Saul J, Toiv N, Cooney C, Beamon T, Borgman M, Bachman G, et al. The evolution of DREAMS: using data for continuous program improvement. AIDS. 2022;36(Suppl 1):S5\u201314.","journal-title":"AIDS"},{"key":"14069_CR24","doi-asserted-by":"crossref","unstructured":"Velloza J, Mujugira A, Muwonge T, Boyer J, Nampewo O, Badaru J, et al. A novel \u201cHIV salience and perception\u201d scale is associated with PrEP dispensing and adherence among adolescent girls and young women in Kampala, Uganda. AIDS Behav. 2022.","DOI":"10.1007\/s10461-022-03762-x"},{"key":"14069_CR25","volume-title":"Working for an equal future: uNICEF policy on gender equality and the empowerment of girls and women","author":"UNICEF","year":"2010","unstructured":"UNICEF. Working for an equal future: uNICEF policy on gender equality and the empowerment of girls and women. New York: UNICEF; 2010."},{"key":"14069_CR26","first-page":"1","volume":"1","author":"M Mbonye","year":"2012","unstructured":"Mbonye M, Nalukenge W, Nakamanya S, Nalusiba B, King R, Vandepitte J, et al. Gender inequity in the lives of women involved in sex work in Kampala, Uganda. J Int AIDS Soc. 2012;15 Suppl 1(Suppl 1): 1\u20139.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"14069_CR27","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1007\/s10461-022-03606-8","volume":"26","author":"R Sundararajan","year":"2022","unstructured":"Sundararajan R, Wyatt MA, Muwonge TR, Pisarski EE, Mujugira A, Haberer JE, et al. Understanding PrEP acceptability among priority populations: results from a qualitative study of potential users in Central Uganda. AIDS Behav. 2022;26(8):2676\u201385.","journal-title":"AIDS Behav"},{"key":"14069_CR28","doi-asserted-by":"publisher","first-page":"101611","DOI":"10.1016\/j.eclinm.2022.101611","volume":"52","author":"R Heffron","year":"2022","unstructured":"Heffron R, Muwonge TR, Thomas KK, Nambi F, Nakabugo L, Kibuuka J, et al. PrEP uptake and HIV viral suppression when PrEP is integrated into Ugandan ART clinics for HIV-negative members of HIV-serodifferent couples: a stepped wedge cluster randomized trial. EClinicalMedicine. 2022;52:101611.","journal-title":"EClinicalMedicine"},{"issue":"27","key":"14069_CR29","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399.","journal-title":"N Engl J Med"},{"key":"14069_CR30","volume-title":"Guideline on when to start antiretroviral therapy and on preexposure prophylaxis for HIV","author":"World Health Organization (WHO)","year":"2015","unstructured":"World Health Organization (WHO). Guideline on when to start antiretroviral therapy and on preexposure prophylaxis for HIV. Geneva: WHO; 2015."},{"key":"14069_CR31","volume-title":"Consolidated guidelines for prevention and treatment of HIV in Uganda","author":"Ministry of Health (MOH)","year":"2016","unstructured":"Ministry of Health (MOH). Consolidated guidelines for prevention and treatment of HIV in Uganda. Kampala: MOH; 2016."},{"issue":"7","key":"14069_CR32","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s10461-020-02780-x","volume":"24","author":"CS Camlin","year":"2020","unstructured":"Camlin CS, Koss CA, Getahun M, Owino L, Itiakorit H, Akatukwasa C, et al. Understanding demand for PrEP and early experiences of PrEP use among young adults in rural Kenya and Uganda: a qualitative study. AIDS Behav. 2020;24(7):2149\u201362.","journal-title":"AIDS Behav"},{"issue":"4","key":"14069_CR33","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s10508-020-01880-y","volume":"50","author":"R Muhumuza","year":"2021","unstructured":"Muhumuza R, Ssemata AS, Kakande A, Ahmed N, Atujuna M, Nomvuyo M, et al. Exploring perceived barriers and facilitators of PrEP uptake among young people in Uganda, Zimbabwe, and South Africa. Arch Sex Behav. 2021;50(4):1729\u201342.","journal-title":"Arch Sex Behav"},{"issue":"5","key":"14069_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s11904-022-00616-y","volume":"19","author":"UM Parikh","year":"2022","unstructured":"Parikh UM, Koss CA, Mellors JW. Long-acting injectable cabotegravir for HIV prevention: what do we know and need to know about the risks and consequences of cabotegravir resistance? Curr HIV\/AIDS Rep. 2022;19(5):384\u201393.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"14069_CR35","unstructured":"Nafula J. Government approves new HIV injectable drug. Dly Monit. 2022."},{"issue":"4","key":"14069_CR36","first-page":"399","volume":"29","author":"MC Cambou","year":"2021","unstructured":"Cambou MC, Landovitz RJ. Challenges and opportunities for preexposure prophylaxis. Top Antivir Med. 2021;29(4):399\u2013406.","journal-title":"Top Antivir Med"},{"issue":"11","key":"14069_CR37","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1007\/s10461-017-2017-x","volume":"22","author":"D Kerrigan","year":"2018","unstructured":"Kerrigan D, Mantsios A, Grant R, Markowitz M, Defechereux P, La Mar M, et al. Expanding the menu of HIV prevention options: a qualitative study of experiences with long-acting injectable cabotegravir as PrEP in the context of a Phase II trial in the United States. AIDS Behav. 2018;22(11):3540\u201349.","journal-title":"AIDS Behav"},{"issue":"7","key":"14069_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med. 2021;385(7):595\u2013608.","journal-title":"N Engl J Med"},{"issue":"8","key":"14069_CR39","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1016\/S2352-3018(17)30074-7","volume":"4","author":"S McCormack","year":"2017","unstructured":"McCormack S, Boffito M. Long-acting cabotegravir for prevention: hope versus reality. Lancet HIV. 2017;4(8):e322\u20133.","journal-title":"Lancet HIV"},{"issue":"4","key":"14069_CR40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/13543784.2018.1460357","volume":"27","author":"TD McPherson","year":"2018","unstructured":"McPherson TD, Sobieszczyk ME, Markowitz M. Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1. Expert Opin Investig Drugs. 2018;27(4):413\u201320.","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"14069_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/15284336.2018.1511346","volume":"19","author":"MI Murray","year":"2018","unstructured":"Murray MI, Markowitz M, Frank I, Grant RM, Mayer KH, Hudson KJ, et al. Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: patient perspectives from the ECLAIR trial. HIV Clin Trials. 2018;19(4):129\u201338.","journal-title":"HIV Clin Trials"},{"issue":"7","key":"14069_CR42","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/infdis\/jiaa296","volume":"224","author":"JA Smith","year":"2021","unstructured":"Smith JA, Garnett GP, Hallett TB. The potential impact of long-acting cabotegravir for HIV prevention in South Africa: a mathematical modeling study. J Infect Dis. 2021;224(7):1179\u201386.","journal-title":"J Infect Dis"},{"issue":"9","key":"14069_CR43","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/infdis\/jiab152","volume":"224","author":"MA Marzinke","year":"2021","unstructured":"Marzinke MA, Grinsztejn B, Fogel JM, Piwowar-Manning E, Li M, Weng L, et al. Characterization of Human Immunodeficiency Virus (HIV) infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083. J Infect Dis. 2021;224(9):1581\u201392.","journal-title":"J Infect Dis"},{"issue":"10337","key":"14069_CR44","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","volume":"399","author":"S Delany-Moretlwe","year":"2022","unstructured":"Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, et al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a Phase 3 randomized clinical trial. Lancet. 2022;399(10337):1779\u201389.","journal-title":"Lancet"},{"issue":"10","key":"14069_CR45","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1093\/infdis\/jiab576","volume":"225","author":"SH Eshleman","year":"2022","unstructured":"Eshleman SH, Fogel JM, Piwowar-Manning E, Chau G, Cummings V, Agyei Y, et al. Characterization of Human Immunodeficiency Virus (HIV) infections in women who received injectable cabotegravir or tenofovir disoproxil fumarate\/emtricitabine for HIV prevention: HPTN 084. J Infect Dis. 2022;225(10):1741\u201349.","journal-title":"J Infect Dis"},{"issue":"Suppl 4","key":"14069_CR46","doi-asserted-by":"publisher","first-page":"S549","DOI":"10.1093\/cid\/ciac752","volume":"75","author":"C Kityo","year":"2022","unstructured":"Kityo C, Cortes CP, Phanuphak N, Grinsztejn B, Venter F. Barriers to uptake of long-acting antiretroviral products for treatment and prevention of HIV in low- and middle-income countries (LMICs). Clin Infect Dis. 2022;75(Suppl 4):S549\u201356.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"14069_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2989\/16085906.2022.2039727","volume":"21","author":"R Kawuma","year":"2022","unstructured":"Kawuma R, Nabalwanyi Z, Seeley J, Mayanja Y. \u201cI prefer to take pills when I plan to have sex\u201d: perceptions of on-demand versus daily oral preexposure prophylaxis among adolescents in Kampala, Uganda. Afr J AIDS Res. 2022;21(1):8\u201314.","journal-title":"Afr J AIDS Res"},{"issue":"1","key":"14069_CR48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12879-022-07398-z","volume":"22","author":"JF Lunkuse","year":"2022","unstructured":"Lunkuse JF, Kamacooko O, Muturi-Kioi V, Chinyenze K, Kuteesa MO, Price MA, et al. Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda. BMC Infect Dis. 2022;22(1):467.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"14069_CR49","doi-asserted-by":"publisher","first-page":"e25909","DOI":"10.1002\/jia2.25909","volume":"25","author":"Y Mayanja","year":"2022","unstructured":"Mayanja Y, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Buzibye A, Omali D, et al. Oral preexposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study. J Int AIDS Soc. 2022;25(5):e25909.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"14069_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/09540121.2022.2052260","volume":"35","author":"F Mwangwa","year":"2022","unstructured":"Mwangwa F, Charlebois ED, Ayieko J, Olio W, Black D, Peng J, et al. Two or more significant life-events in six months are associated with lower rates of HIV treatment and virologic suppression among youth with HIV in Uganda and Kenya. AIDS Care. 2022;35(1):95\u2013105.","journal-title":"AIDS Care"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14069-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14069-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14069-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:03:04Z","timestamp":1773064984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14069-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14069"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14069-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Joint Clinical Research Committee Institutional Review Board\/Ethics Committee in Kampala, Uganda, approved this study (Ref JCRC-2023\u201355) on 14 December 2023. Any modifications to the study protocol that may impact the conduct of the study or patient safety will be sent for IRB approval before implementation. Written informed consent will be obtained by trained study staff fluent in local languages. For minors aged 15\u201317, assent will be obtained along with caregiver consent unless waived by the IRB. Participants will be asked for optional consent for use of their de-identified data and specimens in future ancillary studies related to HIV prevention. A copy of the consent form will be made available to the journal editor for review upon request. Important protocol amendments will be submitted to the IRB, trial registry (ClinicalTrials.gov), and shared with investigators. Participants will be re-consented if amendments affect participation. Major changes will be communicated via reports and publications. Participants will continue to receive standard HIV care per national guidelines. In the event of study-related injury or harm, participants will be referred for care and compensation as outlined in the Uganda National Guidelines for Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}